- Home
- SNYR vs EDSA Comparison
SNYR vs EDSA Comparison
Compare SNYR & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNYR
- EDSA
- Stock Information
- Founded
- SNYR 2010
- EDSA 2015
- Country
- SNYR United States
- EDSA Canada
- Employees
- SNYR N/A
- EDSA N/A
- Industry
- SNYR
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- SNYR
- EDSA Health Care
- Exchange
- SNYR NYSE
- EDSA Nasdaq
- Market Cap
- SNYR 16.6M
- EDSA 13.8M
- IPO Year
- SNYR N/A
- EDSA N/A
- Fundamental
- Price
- SNYR $3.16
- EDSA $2.09
- Analyst Decision
- SNYR Strong Buy
- EDSA Strong Buy
- Analyst Count
- SNYR 1
- EDSA 2
- Target Price
- SNYR $10.00
- EDSA $13.00
- AVG Volume (30 Days)
- SNYR 107.9K
- EDSA 13.3K
- Earning Date
- SNYR 08-24-2025
- EDSA 08-08-2025
- Dividend Yield
- SNYR N/A
- EDSA N/A
- EPS Growth
- SNYR N/A
- EDSA N/A
- EPS
- SNYR 0.30
- EDSA N/A
- Revenue
- SNYR $33,592,914.00
- EDSA N/A
- Revenue This Year
- SNYR $37.83
- EDSA N/A
- Revenue Next Year
- SNYR $18.39
- EDSA N/A
- P/E Ratio
- SNYR $10.26
- EDSA N/A
- Revenue Growth
- SNYR N/A
- EDSA N/A
- 52 Week Low
- SNYR $0.36
- EDSA $1.55
- 52 Week High
- SNYR $10.00
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- SNYR N/A
- EDSA 55.09
- Support Level
- SNYR N/A
- EDSA $2.03
- Resistance Level
- SNYR N/A
- EDSA $2.11
- Average True Range (ATR)
- SNYR 0.00
- EDSA 0.10
- MACD
- SNYR 0.00
- EDSA 0.01
- Stochastic Oscillator
- SNYR 0.00
- EDSA 73.33
About SNYR SYNERGY CHC CORP
Synergy CHC Corp is a provider of consumer health care, beauty, and lifestyle products. It is engaged in the business of marketing and distributing consumer branded products through various distribution channels in the health and wellness industry. The company's products include FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen amongst others. Flat Tummy is a lifestyle and wellness brand that provides a suite of nutritional products to help women achieve their nutrition and weight management goals.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.